Strategic Blueprint’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,720
| Closed | -$252K | – | 667 |
|
|
2024
Q4 | $252K | Sell |
10,720
-3,440
| -24% | -$81K | 0.02% | 567 |
|
|
2024
Q3 | $362K | Sell |
14,160
-2,431
| -15% | -$62.2K | 0.02% | 474 |
|
|
2024
Q2 | $390K | Sell |
16,591
-2,302
| -12% | -$54.1K | 0.03% | 433 |
|
|
2024
Q1 | $543K | Sell |
18,893
-2,586
| -12% | -$74.4K | 0.04% | 364 |
|
|
2023
Q4 | $705K | Sell |
21,479
-2,148
| -9% | -$70.5K | 0.06% | 286 |
|
|
2023
Q3 | $658K | Buy |
23,627
+1,445
| +7% | +$40.3K | 0.06% | 285 |
|
|
2023
Q2 | $756K | Sell |
22,182
-476
| -2% | -$16.2K | 0.07% | 240 |
|
|
2023
Q1 | $681K | Buy |
22,658
+1,909
| +9% | +$57.4K | 0.07% | 249 |
|
|
2022
Q4 | $586K | Buy |
20,749
+742
| +4% | +$20.9K | 0.07% | 265 |
|
|
2022
Q3 | $658K | Buy |
20,007
+3,716
| +23% | +$122K | 0.08% | 236 |
|
|
2022
Q2 | $513K | Sell |
16,291
-1,230
| -7% | -$38.7K | 0.06% | 266 |
|
|
2022
Q1 | $805K | Buy |
17,521
+5,293
| +43% | +$243K | 0.09% | 210 |
|
|
2021
Q4 | $749K | Buy |
12,228
+4,486
| +58% | +$275K | 0.09% | 204 |
|
|
2021
Q3 | $578K | Buy |
7,742
+2,856
| +58% | +$213K | 0.09% | 210 |
|
|
2021
Q2 | $452K | Buy |
4,886
+893
| +22% | +$82.6K | 0.07% | 240 |
|
|
2021
Q1 | $354K | Buy |
+3,993
| New | +$354K | 0.08% | 216 |
|